Ken Griffin Cortexyme, Inc. Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Cortexyme, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,600 shares of CRTX stock, worth $8,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,600
Previous 3,000 120.0%
Holding current value
$8,514
Previous $3,000 166.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
7,163 Added 7.17%
107,007 $138,000
Q2 2024

Aug 14, 2024
BUY
N/A
73,388 Added 277.4%
99,844 $128,000
Q1 2024

May 15, 2024
BUY
N/A
26,456 New
26,456 $34,000
Q4 2022

Feb 14, 2023
BUY
N/A
5,288 New
5,288 $6,000
Q2 2022

Aug 15, 2022
BUY
$2.22 - $6.7 $149,676 - $451,727
67,422 Added 107.31%
130,251 $289,000
Q4 2021

Feb 14, 2022
SELL
$11.35 - $97.17 $355,856 - $3.05 Million
-31,353 Reduced 33.29%
62,829 $792,000
Q3 2021

Nov 15, 2021
BUY
$52.0 - $120.21 $3.2 Million - $7.39 Million
61,465 Added 187.87%
94,182 $8.63 Million
Q1 2021

May 17, 2021
SELL
$28.6 - $49.21 $1.39 Million - $2.4 Million
-48,683 Reduced 59.81%
32,717 $1.18 Million
Q4 2020

Feb 16, 2021
SELL
$27.78 - $56.93 $6.17 Million - $12.6 Million
-222,028 Reduced 73.17%
81,400 $2.26 Million
Q3 2020

Nov 16, 2020
SELL
$39.85 - $57.3 $1.68 Million - $2.41 Million
-42,130 Reduced 12.19%
303,428 $15.2 Million
Q2 2020

Aug 14, 2020
BUY
$34.93 - $57.75 $3.23 Million - $5.33 Million
92,344 Added 36.47%
345,558 $16 Million
Q1 2020

May 15, 2020
BUY
$29.01 - $72.51 $7.16 Million - $17.9 Million
246,796 Added 3845.37%
253,214 $11.5 Million
Q4 2019

Feb 14, 2020
SELL
$20.77 - $68.91 $108,253 - $359,158
-5,212 Reduced 44.82%
6,418 $360,000
Q3 2019

Nov 14, 2019
BUY
$19.85 - $45.28 $230,855 - $526,606
11,630 New
11,630 $289,000

Others Institutions Holding CRTX

# of Institutions
39
Shares Held
5.21M
Call Options Held
90.8K
Put Options Held
0
View Full List

About Cortexyme, Inc.

CRTX Quotes by TradingView
  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email